Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Daratumumab/hyaluronidase 1800mg/30000units/15ml [Brod] (CDM 10455150) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 31, 2026 , from http://ppman.hank.ai/transparency/procedure/10455150/by-state?code_type=CDM
“Daratumumab/hyaluronidase 1800mg/30000units/15ml [Brod] (CDM 10455150) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/10455150/by-state?code_type=CDM. Accessed
October 31, 2026 .
“Daratumumab/hyaluronidase 1800mg/30000units/15ml [Brod] (CDM 10455150) by State,” HANK Price Transparency ,
accessed October 31, 2026 ,
http://ppman.hank.ai/transparency/procedure/10455150/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
10455150 — Daratumumab/hyaluronidase 1800mg/30000units/15ml [Brod]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$28,288
National median
$27,994 – $28,583
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 10455150 (CDM), with interquartile range
State Median p25 p75
NE $28,288 $27,994 $28,583